Table 1:

Participant characteristics

	All cisgender women (N=1431)		Cisgender women meeting CDC indications for PrEP (N=84)		χ2 p-value	Non-PWID MSM (N =1343)		Male PWID (N =77)
	n	%	n	%		n	%	n	%
Race/Ethnicity
Non-Hispanic White	613	43	49	58	0.003	827	62	54	70
Non-Hispanic Black	240	17	4	5	0.002	125	9	4	5
Hispanic/Latino	381	27	19	23	0.392	265	20	11	14
Other/Unknown*	197	14	12	14	0.887	126	9	8	10
Age group
18–24	672	47	23	27	<0.001	419	31	14	18
25–34	462	32	26	31	0.788	479	36	20	26
35–54	261	18	32	38	<0.001	341	25	33	43
55+	36	3	3	4	0.525	104	8	10	13
Year of visit
2013	230	16	17	20	<0.001	243	18	25	32
2014	355	25	28	33	<0.001	344	26	22	29
2015	400	28	19	23	0.248	360	27	11	14
2016	446	31	20	24	0.062	396	29	19	25

Note: χ² p-values compare the characteristics of women meeting CDC indications for PrEP to the general clinic population of women.

PrEP – pre-exposure prophylaxis; CDC – Centers for Disease Control and Prevention; MSM – men who have sex with men; PWID – persons who inject drugs

^*Among all women of other/unknown race/ethnicity, 33% were Asian or Pacific Islander, 6% were American Indian or Alaskan Native, 46% were of another race or ethnicity, and 15% did not report their race/ethnicity.